Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Developing neolignans as proangiogenic agents: Stereoselective total syntheses and preliminary biological evaluations of the four guaiacylglycerol 8-O-4'-coniferyl ethers

dc.contributor.authorBuckler, Joshua
dc.contributor.authorBanwell, Martin
dc.contributor.authorKordbacheh, Farzaneh
dc.contributor.authorParish, Christopher
dc.contributor.authorSantiago, Fernando
dc.contributor.authorKhachigian, Levon M
dc.date.accessioned2021-01-05T00:06:07Z
dc.date.available2021-01-05T00:06:07Z
dc.date.issued2017
dc.date.updated2020-11-23T10:25:04Z
dc.description.abstractStereoselective total syntheses of the four stereoisomeric forms of guaiacylglycerol 8-O-4′-coniferyl ether, viz., compounds 1, ent- 1, 2, and ent- 2, have been established. The key step involves an Evans/Seebach auxiliarycontrolled and syn-selective aldol process followed, in the reaction sequences leading to the anti-compounds, by a Mitsunobu reaction involving a benzylic alcohol residue. The proangiogenic properties of the synthetic materials were evaluated in a human microvascular endothelial cell tubule formation assay, thus revealing that they are all active, with the 8S-configured compounds 1 and 2 being the most potent.en_AU
dc.description.sponsorshipWe thank the National Health and Medical Research Council, the Australian Research Council, and the Institute of Advanced Studies for financial support. J.N.B. is the grateful recipient of a Ph.D. Scholarship provided by the Australian Government. Dr. Hideki Onagi is thanked for assistance with chiral HPLC analyses. L.M.K. is a NH&MRC Australia Fellow.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn2470-1343en_AU
dc.identifier.urihttp://hdl.handle.net/1885/219095
dc.language.isoen_AUen_AU
dc.provenanceThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.en_AU
dc.publisherACS Publicationsen_AU
dc.relationhttp://purl.org/au-research/grants/arc/DP150101947en_AU
dc.rights© 2017 American Chemical Societyen_AU
dc.rights.licenseACS AuthorChoice Licenseen_AU
dc.rights.urihttps://pubs.acs.org/page/policy/authorchoice_termsofuse.htmlen_AU
dc.sourceACS Omegaen_AU
dc.titleDeveloping neolignans as proangiogenic agents: Stereoselective total syntheses and preliminary biological evaluations of the four guaiacylglycerol 8-O-4'-coniferyl ethersen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue10en_AU
local.bibliographicCitation.lastpage7388en_AU
local.bibliographicCitation.startpage7375en_AU
local.contributor.affiliationBuckler, Joshua, College of Science, ANUen_AU
local.contributor.affiliationBanwell, Martin, College of Science, ANUen_AU
local.contributor.affiliationKordbacheh, Farzaneh, College of Health and Medicine, ANUen_AU
local.contributor.affiliationParish, Christopher, College of Health and Medicine, ANUen_AU
local.contributor.affiliationSantiago, Fernando, University of New South Walesen_AU
local.contributor.affiliationKhachigian, Levon M, University of New South Walesen_AU
local.contributor.authoruidBuckler, Joshua, u5064427en_AU
local.contributor.authoruidBanwell, Martin, u9500594en_AU
local.contributor.authoruidKordbacheh, Farzaneh, u4650483en_AU
local.contributor.authoruidParish, Christopher, u6900322en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor111502 - Clinical Pharmacology and Therapeuticsen_AU
local.identifier.absfor110101 - Medical Biochemistry: Amino Acids and Metabolitesen_AU
local.identifier.absseo920103 - Cardiovascular System and Diseasesen_AU
local.identifier.ariespublicationu4351680xPUB461en_AU
local.identifier.citationvolume2en_AU
local.identifier.doi10.1021/acsomega.7b01459en_AU
local.identifier.scopusID2-s2.0-85032622239
local.publisher.urlhttp://pubs.acs.org/journal/acsodfen_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Buckler_Developing_neolignans_as_2017.pdf
Size:
1020.75 KB
Format:
Adobe Portable Document Format
abcd